Glycemic goals and hypoglycemia: Standards of care in diabetes-2025
DOI: Published online: July 1, 2025 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Corresponding author: Hye Jin Yoo Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
Some people think "close enough" is fine
From a therapeutic perspective, GLP-1 receptor agonists drugs that mimic the endogenous hormone GLP-1 are used to treat type 2 diabetes and obesity by improving insulin secretion, lowering blood sugar, and supporting weight reduction
